Biogen Amevive Physician Reimbursement Guaranteed For Insurance Denials
Executive Summary
Biogen will encourage physician uptake of the psoriasis biologic Amevive by guaranteeing reimbursement in cases where insurance coverage is anticipated but later denied
You may also be interested in...
Biogen Closing Gap On Amevive Reimbursement: Pre-Authorization At 30%
The percentage of Amevive patients needing prior authorization for the psoriasis biologic has shrunk to 30%, Biogen Idec CEO Jim Mullen told investors Jan. 12 at the J.P. Morgan health care cconference in San Francisco
Biogen Closing Gap On Amevive Reimbursement: Pre-Authorization At 30%
The percentage of Amevive patients needing prior authorization for the psoriasis biologic has shrunk to 30%, Biogen Idec CEO Jim Mullen told investors Jan. 12 at the J.P. Morgan health care cconference in San Francisco
Biogen Wants To Reduce Amevive Copay, Adds Pharmacy Distribution
Biogen is pursuing initiatives to reduce the copay burden for patients taking the psoriasis agent Amevive